1. Home
  2. SUPN vs WOR Comparison

SUPN vs WOR Comparison

Compare SUPN & WOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$48.46

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Worthington Enterprises Inc.

WOR

Worthington Enterprises Inc.

HOLD

Current Price

$54.44

Market Cap

3.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUPN
WOR
Founded
2005
1955
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Aerospace
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.0B
IPO Year
2010
1996

Fundamental Metrics

Financial Performance
Metric
SUPN
WOR
Price
$48.46
$54.44
Analyst Decision
Strong Buy
Hold
Analyst Count
5
2
Target Price
$61.60
$59.50
AVG Volume (30 Days)
909.5K
350.2K
Earning Date
05-05-2026
03-24-2026
Dividend Yield
N/A
1.41%
EPS Growth
N/A
N/A
EPS
N/A
2.17
Revenue
$392,755,000.00
$1,153,762,000.00
Revenue This Year
$22.70
$22.21
Revenue Next Year
$19.14
$6.03
P/E Ratio
N/A
$24.31
Revenue Growth
N/A
N/A
52 Week Low
$32.21
$45.01
52 Week High
$59.68
$67.80

Technical Indicators

Market Signals
Indicator
SUPN
WOR
Relative Strength Index (RSI) 57.13 43.52
Support Level $47.48 $52.03
Resistance Level $52.36 $56.13
Average True Range (ATR) 1.59 1.97
MACD 0.50 -0.49
Stochastic Oscillator 59.27 27.47

Price Performance

Historical Comparison
SUPN
WOR

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

About WOR Worthington Enterprises Inc.

Worthington Enterprises Inc is a designer and manufacturer of products and services, including manufactured metal products. The company operates under two reportable operating segments: Consumer Products and Building Products. The consumer Products business has a diverse product offering in the tools, outdoor living and celebrations categories, including propane-filled cylinders for torches, handheld torches, specialized hand tools, drywall tools, accessories and gas grills, and others. And the Building Products business engaged in providing pressurized containment solutions, providing critical components in the residential, non-residential, and repair and remodel end markets through essential categories. The company derives majority of the revenue from Building Products segment.

Share on Social Networks: